Literature DB >> 21669513

Theta burst stimulation in the negative symptoms of schizophrenia and striatal dopamine release. An iTBS-[11C]raclopride PET case study.

Jerome Brunelin, David Szekely, Nicolas Costes, Marine Mondino, Thierry Bougerol, Mohamed Saoud, Marie-Françoise Suaud-Chagny, Emmanuel Poulet, Mircea Polosan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21669513     DOI： 10.1016/j.schres.2011.05.019

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  5 in total

1.  Effects of theta-rhythm transcranial alternating current stimulation (4.5 Hz-tACS) in patients with clozapine-resistant negative symptoms of schizophrenia: a case series.

Authors:  Lassaad Kallel; Marine Mondino; Jerome Brunelin
Journal:  J Neural Transm (Vienna)       Date:  2016-05-19       Impact factor: 3.575

2.  Frontal Transcranial Direct Current Stimulation Induces Dopamine Release in the Ventral Striatum in Human.

Authors:  Clara Fonteneau; Jérome Redoute; Frédéric Haesebaert; Didier Le Bars; Nicolas Costes; Marie-Françoise Suaud-Chagny; Jérome Brunelin
Journal:  Cereb Cortex       Date:  2018-07-01       Impact factor: 5.357

3.  Commentary: Effectiveness of theta burst vs. high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomized non-inferiority trial.

Authors:  Cuilan Han; Zhongming Chen; Lin Liu
Journal:  Front Hum Neurosci       Date:  2018-06-25       Impact factor: 3.169

4.  Intermittent theta burst stimulation for negative symptoms of schizophrenia-A double-blind, sham-controlled pilot study.

Authors:  Marine Mondino; Jérôme Brunelin; Rémy Bation; Charline Magnin; Emmanuel Poulet
Journal:  NPJ Schizophr       Date:  2021-02-12

Review 5.  Abnormal striatal dopamine transmission in schizophrenia.

Authors:  Jerome Brunelin; Shirley Fecteau; Marie-Françoise Suaud-Chagny
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.